Journal of Clinical Investigation · 2002 · 289 citations · 43 references
Life SciencesNeurosciencePathologyMolecular NeuroscienceNeurodegenerationNeuropathologyNeurodegenerative DiseasesNeurodegenerative DisordersNeuropathology Of AgingParkinson DiseaseProtein Aggregation DisordersProtein MisfoldingAlpha-synuclein AggregationAlpha-synuclein MisfoldingAmyloid FibrilsLocomotor ImpairmentNeurodegeneration PathogenesisParkinson Disease PathologyProteinase K ResistanceTransgenic Mice
The pathological modifications of -synuclein (S) in Parkinson disease and related diseases are poorly understood. We have detected misfolded S in situ based on the proteinase K resistance (PK resistance) of S fibrils, and using specific antibodies against S129-phosphorylated S as well as oxidized S. Unexpectedly massive neuritic pathology was found in affected human brain regions, in addition to classical S pathology. PK resistance and abnormal phosphorylation of S developed with increasing age in (Thy1)-h[A30P] S transgenic mice, concomitant with formation of argyrophilic, thioflavin S-positive, and electron-dense inclusions that were occasionally ubiquitinated. S pathology in the transgenic mice was predominantly in the brainstem and spinal cord. Astrogliosis was found in these heavily affected tissues. Homozygous mice showed the same pathology approximately one year earlier. The transgenic mice showed a progressive deterioration of locomotor function. Thus, misfolding and hyperphosphorylation of S may cause dysfunction of affected brain regions.
43
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Mihael H. Polymeropoulos, Christian Lavedan, Elisabeth Leroy et al. · Science · 1997 · 8.2K citations
A Drosophila model of Parkinson's disease
Mel Β. Feany, Welcome Bender · Nature · 2000 · 2.1K citations
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Asa Abeliovich, Yvonne Schmitz, Isabel Fariñas et al. · Neuron · 2000 · 1.7K citations · Full text